Andrea Teigler‐Schlegel

Author

Justus-Liebig-Universität Gießen

Also Known As

A Teigler-Schlegel, A. Teigler-Schlegel, Andrea Teigler-Schlegel, Andrea Teigler‐Schlegel, Andrea Teigler‑schlegel

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Justus-Liebig-Universität Gießen Medizinische Hochschule Hannover St Anna Children's Hospital University of Lübeck University Hospital Schleswig-Holstein

About

Andrea Teigler‐Schlegel is an author at Justus-Liebig-Universität Gießen specializing in medicine, hematology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	862
2	Health Sciences	3	3	158
3	Cell Biology	2	2	448
4	Immunology	2	2	35
5	Blood Transplantation	1	1	16

Andrea Teigler‐Schlegel

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
The MLL recombinome of acute leukemias in 2017 Claus Meyer, Thomas Burmeister, Daniela Gröger, Leukemia	2017	670
New insights to the MLL recombinome of acute leukemias Claus Meyer, Eric Kowarz, Jörg Hofmann, Leukemia Hematological MalignancyMixed-phenotype Acute LeukemiaHematologyNew InsightsMedicine	2009	410
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome Christine J. Harrison, Anthony V. Moorman, Claire Schwab, Leukemia Developmental BiologyCytogeneticsGeneticsChromosome BiologyChromosome 21	2013	194
Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study Erik Forestier, Shai Izraeli, Berna Beverloo, Blood	2007	166
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol Petra Dörge, Barbara Meissner, M Zimmermann, Haematologica	2012	165
Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia Eva Ellinghaus, Martin Stanulla, Gesine Richter, Leukemia	2011	134
Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement Susanne Viehmann, Andrea Teigler‐Schlegel, Jochen Bruch, Leukemia Hematological MalignancyOncologyAml1/eto RearrangementMedicineMixed-phenotype Acute Leukemia	2003	95
Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring Claudia Langebrake, Iris Brinkmann, Andrea Teigler‐Schlegel, Cytometry Part B Clinical Cytometry	2004	89
Infant acute lymphoblastic leukemia – combined cytogenetic, immunophenotypical and molecular analysis of 77 cases Arndt Borkhardt, Christian Wuchter, Susanne Viehmann, Leukemia Hematological MalignancyLymphoblastic Leukemia –Molecular AnalysisHematologyPediatrics	2002	74
Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16) Ursula Creutzig, Martin Zimmermann, Jean‐Pierre Bourquin, Blood	2011	64

Page 1